26 February 2024
De Brauw advises underwriters on NewAmsterdam Pharma's USD 200 million public offering of shares and pre-funded warrants
![Gaby Smeenk]( https://dwbxnuhxoazve.cloudfront.net/_576x576_crop_center-center_60_line/gaby.smeenk.jpg 576w)
![Féline Goyarts]( https://dwbxnuhxoazve.cloudfront.net/_576x576_crop_center-center_60_line/feline.goyarts.jpg 576w)
![Henk van Ravenhorst]( https://dwbxnuhxoazve.cloudfront.net/Portraits-colleagues/_576x576_crop_center-center_60_line/henk.vanravenhorst.jpg 576w)
De Brauw advised the underwriters on the USD 200 million public offering of shares and pre-funded warrants by NASDAQ listed NewAmsterdam Pharma Company N.V.